Literature DB >> 2520369

Determination of serum levels of unesterified lathosterol by isotope dilution-mass spectrometry.

E Lund1, L Sisfontes, E Reihner, I Bjorkhem.   

Abstract

The synthesis of 2H3-labelled lathosterol is described. This compound was used together with 2H7-labelled cholesterol for simultaneous assay of unesterified lathosterol and cholesterol in serum by isotope dilution-mass spectrometry. After addition of a fixed amount of the two internal standards to a fixed amount of serum (in general 25 microliter), the steroids were extracted with chloroform and subjected to Lipidex 5000 chromatography. The fraction containing cholesterol and lathosterol was converted into trimethylsilyl ether and subjected to mass spectrometric analysis with selected monitoring of the ions at m/z 458 (molecular ion of the trimethylsilyl ether derivative of unlabelled cholesterol and lathosterol), m/z 461 (molecular ion of derivative of 2H3-labelled lathosterol) and m/z 465 (molecular ion of derivative of 2H7-labelled cholesterol). Individual standard curves were used for assay of each steroid. Under the conditions employed, the coefficient of variation of the two assays was less than 6%. In different recovery experiments the maximal difference between expected and found values was less than 7%. Using a less accurate method for analysis of lathosterol, we have shown previously that there is a high correlation between the hepatic HMG CoA reductase and the relative concentration of unesterified lathosterol in serum (concentration of lathosterol relative to cholesterol). This was confirmed with the present method and a correlation coefficient of about 0.94 was found between the two parameters. It is concluded that the present method may be suitable for detection of cases with accelerated rate of synthesis of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2520369     DOI: 10.3109/00365518909105417

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  20 in total

1.  Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.

Authors:  Natalia Mast; Marjan Shafaati; Wahiduz Zaman; Wenchao Zheng; Deborah Prusak; Thomas Wood; G A S Ansari; Anita Lövgren-Sandblom; Maria Olin; Ingemar Bjorkhem; Irina Pikuleva
Journal:  Biochim Biophys Acta       Date:  2010-03-16

2.  The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.

Authors:  Marjan Shafaati; Natalia Mast; Olof Beck; Rima Nayef; Gun Young Heo; Linda Björkhem-Bergman; Dieter Lütjohann; Ingemar Björkhem; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2009-05-27       Impact factor: 5.922

3.  Abnormalities of cholesterol metabolism in autism spectrum disorders.

Authors:  Elaine Tierney; Irena Bukelis; Richard E Thompson; Khalid Ahmed; Alka Aneja; Lisa Kratz; Richard I Kelley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-09-05       Impact factor: 3.568

4.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

5.  Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice.

Authors:  Natalia Mast; Yong Li; Marlin Linger; Matthew Clark; Jeffrey Wiseman; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

6.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

7.  Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

Authors:  Margaret E Brousseau; Margaret R Diffenderfer; John S Millar; Chorthip Nartsupha; Bela F Asztalos; Francine K Welty; Megan L Wolfe; Mats Rudling; Ingemar Björkhem; Bo Angelin; James P Mancuso; Andres G Digenio; Daniel J Rader; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-10       Impact factor: 8.311

8.  Differential expression and function of ABCG1 and ABCG4 during development and aging.

Authors:  Dragana D Bojanic; Paul T Tarr; Greg D Gale; Desmond J Smith; Dean Bok; Bryan Chen; Steven Nusinowitz; Anita Lövgren-Sandblom; Ingemar Björkhem; Peter A Edwards
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

9.  Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism.

Authors:  J E Akerlund; I Björkhem; B Angelin; L Liljeqvist; K Einarsson
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

10.  Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.

Authors:  Camilla Pramfalk; Michael Pavlides; Rajarshi Banerjee; Catriona A McNeil; Stefan Neubauer; Fredrik Karpe; Leanne Hodson
Journal:  J Clin Endocrinol Metab       Date:  2015-09-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.